PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: In contrast to our results in CML cells, knockdown of PSMD1 and PSMD3 had no effect on colony formation or apoptosis of cord blood CD34+ cells (Fig. 5D, E), suggesting a therapeutic window that could potentially be exploited.